Dr. Habal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 1st Ave 9n
New York, NY 10016Phone+1 646-501-0119Fax+1 646-501-0145
Education & Training
- University of Toronto Faculty of MedicineClass of 2010
Certifications & Licensure
- NY State Medical License 2016 - 2025
Clinical Trials
- Belatacept in De Novo Heart Transplantation Start of enrollment: 2020 Aug 06
Publications & Presentations
PubMed
- 11 citationsT cell repertoire analysis suggest a prominent bystander response in human cardiac allograft vasculopathyMarlena V. Habal, April M.I Miller, Samhita Rao, Sijie Lin, Aleksandar Obradovic
American Journal of Transplantation. 2021-04-01 - 143 citationsCharacteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.Farhana Latif, Maryjane Farr, Kevin J. Clerkin, Marlena V. Habal, Koji Takeda
JAMA Cardiology. 2020-05-13 - 15 citationsPredictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy.Arthur R. Garan, Waqas Malick, Marlena V. Habal, Veli K. Topkara, Justin Fried
ASAIO Journal. 2019-11-01
Press Mentions
- Broken HeartsFebruary 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: